187 related articles for article (PubMed ID: 33973539)
41. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis.
Grin PM; Kowalewska PM; Alhazzan W; Fox-Robichaud AE
Can J Urol; 2013 Feb; 20(1):6607-14. PubMed ID: 23433130
[TBL] [Abstract][Full Text] [Related]
42. Behavioral and dietary risk factors of recurrent urinary tract infection in Chinese postmenopausal women: a case-control study.
Zhu M; Wang S; Zhu Y; Wang Z; Zhao M; Chen D; Zhou C
J Int Med Res; 2020 Mar; 48(3):300060519889448. PubMed ID: 31840544
[TBL] [Abstract][Full Text] [Related]
43. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.
Kochiashvili D; Khuskivadze A; Kochiashvili G; Koberidze G; Kvakhajelidze V
Georgian Med News; 2014 Jun; (231):11-6. PubMed ID: 25020163
[TBL] [Abstract][Full Text] [Related]
44. Cranberries for preventing urinary tract infections.
Jepson RG; Williams G; Craig JC
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD001321. PubMed ID: 23076891
[TBL] [Abstract][Full Text] [Related]
45. Evidence-based review of nonantibiotic urinary tract infection prevention strategies for women: a patient-centered approach.
Stair SL; Palmer CJ; Lee UJ
Curr Opin Urol; 2023 May; 33(3):187-192. PubMed ID: 36862100
[TBL] [Abstract][Full Text] [Related]
46. Financial Burden of Recurrent Urinary Tract Infections in Women: A Time-driven Activity-based Cost Analysis.
Gaitonde S; Malik RD; Zimmern PE
Urology; 2019 Jun; 128():47-54. PubMed ID: 30796990
[TBL] [Abstract][Full Text] [Related]
47. [Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women].
Xu R; Wu Y; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):531-3. PubMed ID: 11769665
[TBL] [Abstract][Full Text] [Related]
48. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
[TBL] [Abstract][Full Text] [Related]
49. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
50. Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.
Javed AA; Mayhew AJ; Shea AK; Raina P
JAMA Netw Open; 2019 Aug; 2(8):e1910154. PubMed ID: 31461147
[TBL] [Abstract][Full Text] [Related]
51. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
[TBL] [Abstract][Full Text] [Related]
52. Urinary Tract Infections After Urogynecologic Surgery: Risk Factors, Timeline, and Uropathogens.
Jung CE; Chen LH; Brubaker LT; Menefee SA
Urogynecology (Phila); 2023 Jul; 29(7):632-640. PubMed ID: 36701315
[TBL] [Abstract][Full Text] [Related]
53. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
Trials; 2016 Jul; 17():358. PubMed ID: 27460108
[TBL] [Abstract][Full Text] [Related]
54. Inflammatory markers for improved recurrent UTI diagnosis in postmenopausal women.
Ebrahimzadeh T; Basu U; Lutz KC; Gadhvi J; Komarovsky JV; Li Q; Zimmern PE; De Nisco NJ
Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38331474
[TBL] [Abstract][Full Text] [Related]
55. The Urinary Microbiome in Postmenopausal Women with Recurrent Urinary Tract Infections.
Vaughan MH; Mao J; Karstens LA; Ma L; Amundsen CL; Schmader KE; Siddiqui NY
J Urol; 2021 Nov; 206(5):1222-1231. PubMed ID: 34181466
[TBL] [Abstract][Full Text] [Related]
56. Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives.
De Nunzio C; Bartoletti R; Tubaro A; Simonato A; Ficarra V
Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33915821
[TBL] [Abstract][Full Text] [Related]
57. Recurrent Urinary Tract Infection Incidence Rates Decrease in Women With Cystitis Cystica After Treatment With d-Mannose: A Cohort Study.
Chiu K; Zhang F; Sutcliffe S; Mysorekar IU; Lowder JL
Female Pelvic Med Reconstr Surg; 2022 Mar; 28(3):e62-e65. PubMed ID: 35272335
[TBL] [Abstract][Full Text] [Related]
58. Impact of Vaginal Estrogen on the Urobiome in Postmenopausal Women With Recurrent Urinary Tract Infection.
Jung CE; Estaki M; Chopyk J; Taylor BC; Gonzalez A; McDonald D; Shin J; Ferrante K; Wasenda E; Lippmann Q; Knight R; Pride D; Lukacz ES
Female Pelvic Med Reconstr Surg; 2022 Jan; 28(1):20-26. PubMed ID: 33978602
[TBL] [Abstract][Full Text] [Related]
59. Urine and vaginal microbiota compositions of postmenopausal and premenopausal women differ regardless of recurrent urinary tract infection and renal transplant status.
Hugenholtz F; van der Veer C; Terpstra ML; Borgdorff H; van Houdt R; Bruisten S; Geerlings SE; van de Wijgert JHHM
Sci Rep; 2022 Feb; 12(1):2698. PubMed ID: 35177690
[TBL] [Abstract][Full Text] [Related]
60. Urinary tract infection in postmenopausal women.
Raz R
Korean J Urol; 2011 Dec; 52(12):801-8. PubMed ID: 22216390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
